SMTI shares should trade near the implied $35.00 consideration with a modest spread reflecting closing risk. Monitor the S-4 registration statement for the proxy/prospectus and watch for any regulatory or shareholder opposition. The spread may narrow as the closing date approaches. MiMedx's Q2 earnings call later today may provide additional color on deal financing and synergies.
Price Chart
Executive Summary
Sanara MedTech announced a definitive agreement to be acquired by MiMedx Group in a cash-and-stock transaction valued at approximately $350 million. Shareholders will receive $33.00 cash plus 0.4735 MiMedx shares per Sanara share, implying total consideration of ~$35.00/share and a 46% premium to the 30-day VWAP. The deal, unanimously approved by both boards, is expected to close by year-end subject to shareholder and regulatory approvals.
Key Financial Metrics
Key Facts
- Total enterprise value of ~$350 million
- Per-share consideration: $33.00 cash + 0.4735 MiMedx shares (valued at ~$2.00 based on $4.22 MiMedx VWAP) = ~$35.00/share
- 46% premium to Sanara's 30-day VWAP as of July 28, 2026
- Transaction unanimously approved by both boards
- Expected to close by end of 2026, subject to Sanara shareholder vote and regulatory approvals
- Sanara conducted a strategic review with independent financial and legal advisors
Financial Impact
Sanara shareholders receive ~$35.00/share in cash and stock, a 46% premium to the unaffected 30-day VWAP. The deal values Sanara at ~$350 million enterprise value.
Risk Factors
- Failure to obtain Sanara shareholder approval
- Regulatory delays or antitrust concerns
- Termination fee if deal falls through
- Market price of MiMedx stock could affect the stock portion's value
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (SMTI) — Batch item 1 | 0001493152-26-035405 |
| Document: 0001493152-26-035405-index-headers.html | 0001493152-26-035407 |
| Document: 0001493152-26-035405.txt | 0001493152-26-035405 |
| 425 Filing (SMTI) — Batch item 4 | 0001493152-26-035407 |
| Document: 0001493152-26-035407-index-headers.html | 0001493152-26-035405 |
| Document: 0001493152-26-035407.txt | 0001493152-26-035405 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 425 | $33.16 $32.80 | ▲ +1.09% | ▲ +1.18% | $32.84 (+0.97%) |
Oct 16, 2026 11d ago | 8-K | $33.16 $32.80 | ▼ −1.09% | ▼ −1.18% | $32.84 (−0.97%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jul 30, 2026 12w ago | 425 | $34.06 $34.09 | ▲ +0.09% | ▼ −3.53% | $32.84 (−3.58%) |
Jun 4, 2026 20w ago | 8-K | $22.44 $20.81 | ▼ −7.26% | ▼ −7.83% | $32.84 (+46.35%) |
May 11, 2026 24w ago | 8-K | $20.44 $21.89 | ▲ +7.09% | ▲ +7.02% | $32.84 (+60.67%) |
Apr 17, 2026 27w ago | DEFA14A | $20.62 $18.93 | ▼ −8.20% | ▼ −9.11% | $32.84 (+59.26%) |
Apr 17, 2026 27w ago | DEFA14A | $20.77 $19.22 | ▼ −7.46% | ▼ −8.02% | $32.84 (+58.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers